Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Peter

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
IJID Regions|March 30, 2026
High two-month mortality in Gabonese adults with and without tuberculosis: A prospective cohort study of patients with presumed pulmonary tuberculosisStefan Fabian Weber, Anne Glaser, Bayodé Roméo Adegbite, et al.
Journal of Clinical Pharmacology|September 30, 2024
Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 StudyRamachandra Sangana, Bernhards Ogutu, Adoke Yeka, et al.
The Lancet. Infectious Diseases|June 16, 2023
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trialBernhards Ogutu, Adoke Yeka, Sylvia Kusemererwa, et al.
Annals of Clinical Microbiology and Antimicrobials|May 9, 2025
Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of CongoBreli Bonheur Ngouama, Jean Claude Djontu, Darrel Ornelle Elion Assiana, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
IJID Regions|March 30, 2026
High two-month mortality in Gabonese adults with and without tuberculosis: A prospective cohort study of patients with presumed pulmonary tuberculosisStefan Fabian Weber, Anne Glaser, Bayodé Roméo Adegbite, et al.
Journal of Clinical Pharmacology|September 30, 2024
Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 StudyRamachandra Sangana, Bernhards Ogutu, Adoke Yeka, et al.
The Lancet. Infectious Diseases|June 16, 2023
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trialBernhards Ogutu, Adoke Yeka, Sylvia Kusemererwa, et al.
Annals of Clinical Microbiology and Antimicrobials|May 9, 2025
Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of CongoBreli Bonheur Ngouama, Jean Claude Djontu, Darrel Ornelle Elion Assiana, et al.
Pageof 12